These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34867953)

  • 1. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Kornfeld H; Babu S
    Front Immunol; 2021; 12():731878. PubMed ID: 34867953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment.
    Kathamuthu GR; Moideen K; Kumar NP; Sridhar R; Baskaran D; Babu S
    PLoS One; 2020; 15(5):e0233426. PubMed ID: 32470023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
    Jacobs R; Tshehla E; Malherbe S; Kriel M; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
    Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Ahamed SF; Ponnuraja C; Hissar S; Kornfeld H; Babu S
    Clin Infect Dis; 2022 Nov; 75(10):1820-1826. PubMed ID: 35352112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.
    Kedia K; Wendler JP; Baker ES; Burnum-Johnson KE; Jarsberg LG; Stratton KG; Wright AT; Piehowski PD; Gritsenko MA; Lewinsohn DM; Sigal GB; Weiner MH; Smith RD; Jacobs JM; Nahid P
    Tuberculosis (Edinb); 2018 Sep; 112():52-61. PubMed ID: 30205969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis.
    Yan L; Xiao H; Zhang Q
    BMC Infect Dis; 2018 Oct; 18(1):512. PubMed ID: 30309331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease.
    Andrade BB; Pavan Kumar N; Mayer-Barber KD; Barber DL; Sridhar R; Rekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
    PLoS One; 2013; 8(5):e62618. PubMed ID: 23671613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
    Soedarsono S; Subiantoro MC
    Indian J Tuberc; 2019 Jan; 66(1):134-138. PubMed ID: 30797271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Sci Rep; 2019 Dec; 9(1):18217. PubMed ID: 31796883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sequential changes of serum acute phase reactants in response to antituberculous chemotherapy].
    Suzuki K; Takashima Y; Yamada T; Akiyama J; Yagi K; Kawashima M; Sato M
    Kekkaku; 1992 Apr; 67(4):303-11. PubMed ID: 1376373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
    Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
    Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis.
    Lawn SD; Obeng J; Acheampong JW; Griffin GE
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):340-4. PubMed ID: 10777083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Banurekha VV; Nair D; Sridhar R; Baskaran D; Babu S
    PLoS One; 2018; 13(11):e0207404. PubMed ID: 30427928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children.
    Albuquerque VVS; Kumar NP; Fukutani KF; Vasconcelos B; Arriaga MB; Silveira-Mattos PS; Babu S; Andrade BB
    Cytokine; 2019 Nov; 123():154773. PubMed ID: 31299414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.